Melissa D Johnson

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 8

Top Topics

Clinical Practice

Drug Administration

Top Venues

Pharmacotherapy

Infection control and hospital epidemiology

This page only lists publications with an associated author ORCID identifier.

Publications

David B Cluck, Daniel B Chastain, Milena M McLaughlin, Spencer H Durham, Elias B Chahine, Caroline Derrick, Julie B Dumond, E Kelly Hester, Sarah B Jeter, Melissa D Johnson, Christin Kilcrease, Wesley D Kufel, Jeffrey Kwong, Amber F Ladak, Nimish Patel, Sarah E Pérez, Jonell B Poe, Charlotte A Bolch, Ian Thomas, Elizabeth Asiago-Reddy, William R Short
Consensus recommendations for the use of novel antiretrovirals in persons with HIV who are heavily treatment-experienced and/or have multidrug-resistant HIV-1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy. Pharmacotherapy 44 (5) (2024)
David B Cluck, Daniel B Chastain, Milena M McLaughlin, Spencer H Durham, Elias B Chahine, Caroline Derrick, Julie B Dumond, E Kelly Hester, Sarah B Jeter, Melissa D Johnson, Christin Kilcrease, Wesley D Kufel, Jeffrey Kwong, Amber F Ladak, Nimish Patel, Sarah E Pérez, Jonell B Poe, Charlotte A Bolch, Ian Thomas, Elizabeth Asiago-Reddy, William R Short
Consensus recommendations for the use of novel antiretrovirals in persons with HIV who are heavily treatment-experienced and/or have multidrug-resistant HIV-1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy. Pharmacotherapy 44 (5) (2024)
David B Cluck, Daniel B Chastain, Milena M McLaughlin, Spencer H Durham, Elias B Chahine, Caroline Derrick, Julie B Dumond, E Kelly Hester, Sarah B Jeter, Melissa D Johnson, Christin Kilcrease, Wesley D Kufel, Jeffrey Kwong, Amber F Ladak, Nimish Patel, Sarah E Pérez, Jonell B Poe, Charlotte A Bolch, Ian Thomas, Elizabeth Asiago-Reddy, William R Short
Consensus recommendations for the use of novel antiretrovirals in persons with HIV who are heavily treatment-experienced and/or have multidrug-resistant HIV-1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy: An executive summary. Pharmacotherapy 44 (5) (2024)
David B Cluck, Daniel B Chastain, Milena M McLaughlin, Spencer H Durham, Elias B Chahine, Caroline Derrick, Julie B Dumond, E Kelly Hester, Sarah B Jeter, Melissa D Johnson, Christin Kilcrease, Wesley D Kufel, Jeffrey Kwong, Amber F Ladak, Nimish Patel, Sarah E Pérez, Jonell B Poe, Charlotte A Bolch, Ian Thomas, Elizabeth Asiago-Reddy, William R Short
Consensus recommendations for the use of novel antiretrovirals in persons with HIV who are heavily treatment-experienced and/or have multidrug-resistant HIV-1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy: An executive summary. Pharmacotherapy 44 (5) (2024)
Erin K McCreary, Matthew R Davis, Navaneeth Narayanan, David R Andes, Dario Cattaneo, Robbie Christian, Russell E Lewis, Kevin M Watt, Nathan P Wiederhold, Melissa D Johnson
Utility of Triazole Antifungal Therapeutic Drug Monitoring: Insights from the Society of Infectious Diseases Pharmacists. Pharmacotherapy (2023)
Rebekah W Moehring, Angelina Davis, Elizabeth Dodds Ashley, April P Dyer, Richard H Drew, Yuliya Loknyghina, Melissa D Johnson, Travis M Jones, S Shaefer Spires, Daniel J Sexton, Deverick J Anderson
Harvesting the low-hanging fruit? Comparative assessment of intravenous to oral route antimicrobial conversion policy implementation. Infection control and hospital epidemiology (2022)
Alexandra A Johnson, Bobby G Warren, Deverick J Anderson, Melissa D Johnson, Isabella Gamez, Becky A Smith
Impact of alcohol-based hand-rub disinfection on bacterial bioburden on stethoscopes in a real-world clinical setting. Infection control and hospital epidemiology (2022)
Andrew M Strand, Barbara Dudley Alexander, Eric Sarpong, Jessica Retuerto Wong, Ashley Engemann, David Rizzieri, Yuan Wu, Melissa D Johnson
Real-world effectiveness of antifungal prophylaxis with posaconazole as the primary agent in patients with haematological malignancies. Mycoses 65 (11) (2022)